Equity (Details) |
2 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 07, 2022 |
Oct. 10, 2022
shares
|
Oct. 10, 2022
USD ($)
shares
|
Sep. 28, 2022
USD ($)
|
Sep. 28, 2022 |
Oct. 23, 2022
USD ($)
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
|
Oct. 04, 2022
$ / shares
shares
|
Jul. 05, 2022
$ / shares
shares
|
Dec. 31, 2019
$ / shares
shares
|
Oct. 10, 2018
shares
|
Feb. 08, 2018
$ / shares
shares
|
|||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | $ 0.0001 | |||||||||||||
Exchangeable shares | 18,094 | ||||||||||||||
Special voting preferred stock, description | reverse stock split of the outstanding shares of Common Stock by a ratio of 20 for 1 | ||||||||||||||
Preferred stock, liquidation preference (in dollars per share) | $ / shares | $ 1 | ||||||||||||||
Exchangable shares, issued | 904 | ||||||||||||||
Exchangeable shares, outstanding | 291,192 | ||||||||||||||
Purchase price per unit (in dollars per share) | $ / shares | $ 3.518 | ||||||||||||||
Exercise price | $ / shares | $ 4.6 | ||||||||||||||
Exchange ratio of converted warrants upon conversion | 1 | ||||||||||||||
Description of unit offering | (i) 29,382,861 units consisting of 1,469,143 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 1,469,143 shares of Common Stock (together, the “Units”) and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-funded Warrants”) to purchase 704,770 shares of Common Stock, together with Common Warrants to purchase up to 704,770 shares of Common Stock (together, the “Pre-funded Units”). The Units were sold at a public offering price of $0.23 per unit and the Pre-funded Units were sold at a public offering price of $0.2299 per pre-funded unit. | ||||||||||||||
Underwriting Agreement, Description | (i) an increase to Common Stock of $217 representing the issuance of 1,469,143 shares of Common Stock attributable to the Units and the issuance of 704,770 shares of Common Stock from the exercise of the Pre-funded Warrants<span>, both at their par value of $0.0001 per share </span>and (ii) an increase to Additional Paid-In Capital of $9.2 million for the amounts received over par value less the underwriting discounts and commissions and related expenses <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">including legal and other professional fees</span>. | ||||||||||||||
Net proceeds | $ | $ 9,200,000 | ||||||||||||||
Convertible Notes (at fair value) | $ | $ 7,000,000 | ||||||||||||||
Warrants outstanding | 45,652,174 | ||||||||||||||
Common warrants shares | 43,478,261 | ||||||||||||||
Aggregate value of exchangeable shares | $ | $ 138,419 | ||||||||||||||
Outstanding exchanged for shares | 14,560 | ||||||||||||||
Effective date | Jun. 29, 2022 | ||||||||||||||
Warrants issued | 59,747,574 | ||||||||||||||
Convertible Redeemable Preferred Stock [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Convertible redeemable preferred stock, description | The holders of all of the Convertible Redeemable Preferred Stock redeemed their shares for cash at 105% of the stated value, or $10.50 per share, of such shares on November 9, 2022. Accordingly, we directed the escrow agent to pay $5.25 million on November 10, 2022 to the holders from the escrow account established upon the date of the Convertible Redeemable Preferred Stock offering. | ||||||||||||||
Exchangeable shares | 3,294,580 | ||||||||||||||
Series B Preferred Stock [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Preferred stock, shares issued | 100,000 | ||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | ||||||||||||||
Series A Preferred Stock [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Preferred stock, shares issued | 400,000 | ||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | ||||||||||||||
ATM Program [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Sale of common stock | 118,629 | 90,809 | |||||||||||||
Aggregate purchase price | $ | $ 20 | $ 2,700,000 | $ 800,000 | $ 25,000,000 | |||||||||||
Sale of stock, description | (the “2022 ATM Program”) from time to time through AGP as the sales agent for which they will receive a commission of 3.0% of the gross proceeds. The 2022 ATM Program is currently limited to $3.5 million due to certain restrictions imposed by the registration statement underlying the offering (the “Baby Shelf Limitation”). Under the Baby Shelf Limitation, we may not offer Common Stock under the registration statement with a value of more than one-third of the aggregate market value of our Common Stock held by non-affiliates in any twelve-month period, so long as the aggregate market value of our Common Stock held by non-affiliates is less than $75.0 million. | ||||||||||||||
Public Warrant [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Exchangeable shares | 290,690 | ||||||||||||||
Private Warrant [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Exercise price | $ / shares | $ 230 | $ 230 | |||||||||||||
Mtech [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Number of shares issued | 287,500 | ||||||||||||||
Mtech [Member] | Public Warrant [Member] | Over-Allotment Option [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Shares sold | 37,500 | ||||||||||||||
Mtech [Member] | Public Warrant [Member] | IPO [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Purchase price per unit (in dollars per share) | $ / shares | $ 200 | ||||||||||||||
Exercise price | $ / shares | 230 | ||||||||||||||
Mtech [Member] | Private Warrant [Member] | Private Placement [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Purchase price per unit (in dollars per share) | $ / shares | $ 200 | ||||||||||||||
Shares sold | 12,187 | ||||||||||||||
Exercise price | $ / shares | $ 230 | ||||||||||||||
Pre-Funded Warrants [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Exercise price | $ / shares | $ 0.002 | ||||||||||||||
Warrants issued | 14,095,400 | ||||||||||||||
Underwriter Warrants [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Exchangeable shares | 108,696 | ||||||||||||||
Exercise price | $ / shares | [1] | $ 4.6 | |||||||||||||
Warrants issued | [1] | 2,173,913 | |||||||||||||
Underwriter Warrants [Member] | IPO [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Exercise price | $ / shares | $ 3.518 | ||||||||||||||
Underwriter Warrants [Member] | Minimum [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Underwriter warrants to purchase | 108,696 | ||||||||||||||
Common Warrant [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Sale of common stock | 2,282,609 | ||||||||||||||
Exercise price | $ / shares | [1] | $ 4.6 | |||||||||||||
Common warrants shares | 2,173,913 | ||||||||||||||
Warrants issued | [1] | 43,478,261 | |||||||||||||
Subsequent Event [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Sale of common stock | 2,282,609 | ||||||||||||||
Shares sold | 402,345 | 402,345 | |||||||||||||
Gross purchase price | $ | $ 900,000 | ||||||||||||||
Subsequent Event [Member] | Convertible Redeemable Preferred Stock [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Convertible redeemable preferred stock, description | (the “Series B Preferred Stock”, and together with the Series A Preferred Stock, the “Convertible Redeemable Preferred Stock”), at an offering price of $9.50 per share, representing a 5% original issue discount to the stated value of $10.00 per share, for gross proceeds of approximately $4.75 million in the aggregate, before the deduction of the fees and offering expenses of our financial advisor. The aggregate net proceeds (after deducting the fees and expenses of our financial advisor) together with the additional amount to provide for the 105% redemption premium on the Convertible Redeemable Preferred Stock was deposited in an account with an escrow agent. The shares of the Convertible Redeemable Preferred Stock are convertible, at a conversion price of $0.25 per share (subject in certain circumstances to adjustments), into shares of our Common Stock, at the option of the holders and, in certain circumstances, by the Company. | ||||||||||||||
Warrant [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Underwriting Agreement, Description | We granted the Underwriter a 45-day option from the effective date of the 2022 Unit Offering to purchase from us (i) additional shares of Common Stock and/or (ii) Common Warrants and/or (iii) Pre-Funded Warrants, in any combination thereof solely to cover over-allotments | ||||||||||||||
Warrants outstanding | 20 | 20 | |||||||||||||
Common Stock [Member] | |||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||
Number of securities called by each warrant or right | 9,468 | ||||||||||||||
Underwriter warrants to purchase | 2,173,913 | ||||||||||||||
Common warrants shares | 1 | 1 | |||||||||||||
Common stock per share | $ / shares | $ 230 | ||||||||||||||
Exercised shares | 704,770 | ||||||||||||||
|